Silicon Laboratories Reports Better Than Expected First Quarter Results and Strong Outlook

* Reuters is not responsible for the content in this press release.

Wed Apr 29, 2009 8:00am EDT

CompanyDemonstrates Good Expense Control and Generates Solid Cash Flow
AUSTIN, Texas--(Business Wire)--
Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance,
analog-intensive, mixed-signal integrated circuits (ICs), today reported first
quarter revenue of $83.7 million. The company`s expense controls, better than
expected revenue and model gross margin resulted in better than anticipated
earnings per share performance and solid cash generation in the quarter. 

First Quarter Financial Results

First quarter revenue of $83.7 million declined 16 percent sequentially versus
the original projection of a 20 to 25 percent decline. Strong operating
performance allowed the company to remain profitable on a GAAP basis. First
quarter GAAP gross margin was flat sequentially at 60.5 percent. R&D investment
for the period declined to $26.1 million and SG&A declined to $23.4 million.
GAAP diluted earnings per share was one cent, significantly better than
originally anticipated. Cash flow from operations was nearly $12 million. 

The following non-GAAP results exclude the impact of stock compensation expense
and other one-time charges. Non-GAAP gross margin held at the midpoint of the
company`s target range at 61 percent. Non-GAAP operating expenses declined five
percent sequentially to $38.9 million as a result of tight controls over
discretionary spending. Non-GAAP operating income was 14.5 percent at $12.1
million, an excellent result. Non-GAAP diluted earnings per share were $0.22,
considerably better than anticipated. The reconciling charges are set forth in
the financial measures table below. 

During the first quarter, accounts receivable returned to normal levels as
demand improved throughout the quarter. Inventory decreased again sequentially
to $23.5 million. The company repurchased $5 million in shares and ended the
quarter with a higher level of cash, cash equivalents and investments at $326
million. 

Business Summary

The company`s notable performance during the quarter was due primarily to
several key customers gaining share in their respective markets and new product
cycles. 

The Broad-based business increased almost 15 percent year over year driven by
growth in the timing and power businesses. Increasing share and new product
momentum experienced during the first quarter is expected to continue into the
second quarter. The RF business declined less than anticipated due to a strong
ramp of the video demodulator with a major customer, as well as relatively
better handset demand. Handsets represented the dominant share of the audio
revenue, and new design win activity was strong. The Access business declined
sequentially as customers reduced inventory levels. All three businesses,
Broad-based, RF and Access are expected to grow sequentially in the second
quarter. 

"With the first quarter behind us, we are feeling good about our business, even
in light of what we recognize is a very weak global economy," said Necip
Sayiner, president and CEO of Silicon Laboratories. "We see Q1 as the cyclical
bottom in terms of revenue and expect to benefit from strong product cycles and
share gains going forward. We believe that our ability to hold margins, sustain
our profitability and generate cash despite the depressed revenue puts us in a
select group of companies well equipped to outperform this year." 

For the second quarter of 2009, the company is guiding revenue in the range of
$92 to $97 million. 

Webcast and Conference Call

A conference call discussing the results will follow this press release today at
7:30 a.m. Central Time. An audio webcast will be available simultaneously on
Silicon Laboratories` website under Investor Relations (www.silabs.com). A
replay will be available after the call at the same website listed above or by
calling 1-866-415-2341 or +1 203-369-0686 (international). Replays will be
available through May 13, 2009. 

About Silicon Laboratories Inc.

Silicon Laboratories Inc. is a leading designer of high-performance,
analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of
applications. Silicon Laboratories` diverse portfolio of highly integrated,
patented solutions is developed by a world-class engineering team with expertise
in cutting-edge mixed-signal design. The company has design, engineering,
marketing, sales and applications offices throughout North America, Europe and
Asia. For more information about Silicon Laboratories, please visit
www.silabs.com. 

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon
Laboratories` current expectations. The words "believe," "estimate," "expect,"
"intend," "anticipate," "plan," "project," "will" and similar phrases as they
relate to Silicon Laboratories are intended to identify such forward-looking
statements. These forward-looking statements reflect the current views and
assumptions of Silicon Laboratories and are subject to various risks and
uncertainties that could cause actual results to differ materially from
expectations. Among the factors that could cause actual results to differ
materially from those in the forward-looking statements are the following: risks
that Silicon Laboratories may not be able to maintain its historical growth;
quarterly fluctuations in revenues and operating results; volatile stock price;
average selling prices of products may decrease significantly and rapidly,
dependence on a limited number of products and customers; difficulties
developing new products that achieve market acceptance; risks that Silicon
Laboratories may not be able to manage strains associated with its growth;
dependence on key personnel; difficulties managing our manufacturers and
subcontractors; difficulties managing international activities; credit risks
associated with our accounts receivable; geographic concentration of
manufacturers, assemblers, test service providers and customers in Asia that
subjects Silicon Laboratories` business and results of operations to risks of
natural disasters, epidemics, war and political unrest; product development
risks; inventory-related risks; intellectual property litigation risks; risks
associated with acquisitions (including risks that acquisitions may not yield
the expected benefits due to the failure to properly integrate the acquired
businesses and employees; risks that the customer base and revenue of the
acquired businesses may cease to expand or may decline; risks that the acquired
business` products under development may fail to achieve market acceptance;
risks of disputes regarding the acquired business; risks that the performance of
Silicon Laboratories` existing business may not offset the dilutive effect of an
acquisition); risks associated with divestitures; the competitive and cyclical
nature of the semiconductor industry and other factors that are detailed in
Silicon Laboratories` filings with the SEC. Silicon Laboratories disclaims any
intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. 

Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo
are trademarks of Silicon Laboratories Inc. All other product names noted herein
may be trademarks of their respective holders.

 Silicon Laboratories Inc.                                                                           
 
Condensed Consolidated Statements of Income                                                        
 
(In thousands, except per share data)                                                              
 
(Unaudited)                                                                                        
                                                                                                   
                                                Three Months Ended                                 
                                                April 4,                   April 5,              
                                                2009                       2008                  
 Revenues                                       $     83,701             $     98,179        
 Cost of revenues                                     33,023                   37,832        
 Gross margin                                         50,678                   60,347        
 Operating expenses:                                                                             
 Research and development                             26,069                   24,673        
 Selling, general and administrative                  23,442                   24,609        
 Operating expenses                                   49,511                   49,282        
 Operating income                                     1,167                    11,065        
 Other income (expense):                                                                         
 Interest income                                      882                      4,798         
 Interest expense                                     (52     )                (145    )     
 Other income (expense), net                          (52     )                (142    )     
 Income before income taxes                           1,945                    15,576        
 Provision for income taxes                           1,274                    4,762         
 Net income                                     $     671                $     10,814        
                                                                                                 
 Earnings per share:                                                                             
 Basic                                          $     0.02               $     0.21          
 Diluted                                        $     0.01               $     0.21          
                                                                                                 
 Weighted-average common shares outstanding:                                                     
 Basic                                                44,633                   51,109        
 Diluted                                              45,083                   52,000        


 Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures                                                                                                             
 
(In thousands, except per share data)                                                                                                                                      
                                                                                                                                                                           
 Non-GAAP Income               Three Months Ended                                                                                                                          
 Statement Items               April 4, 2009                                                                                                                               
                               GAAP                GAAP                       Stock                  Termination            Non-GAAP            Non-GAAP         
                               Measure             Percent of                 Compensation           Costs and              Measure             Percent of       
                                                   Revenue                    Expense                Impairments                                Revenue          
 Revenues                      $      83,701                                                                                                                    
                                                                                                                                                                 
 Gross margin                         50,678             60.5   %          $        395          $        10           $      51,083      61.0    %       
                                                                                                                                                                 
 Operating expenses                   49,511             59.1   %                   9,754                 811                 38,946      46.5    %       
                                                                                                                                                                 
 Operating income                     1,167              1.4    %                   10,149                821                 12,137      14.5    %       
                                                                                                                                                                 
                                                                                                                                                                 
 Non-GAAP Diluted              Three Months Ended                                                                                                                      
 Earnings Per Share            April 4, 2009                                                                                                                           
                               GAAP                Stock                      Termination            Non-GAAP                                                    
                               Measure             Compensation               Costs and              Measure                                                     
                                                   Expense                    Impairments                                                                        
 Net Income                    $      671         $      8,641             $        732          $        10,044                                            
                                                                                                                                                                 
 Diluted shares outstanding           45,083             --                         --                    45,083                                            
                                                                                                                                                                 
 Diluted earnings per share    $      0.01                                                          $        0.22                                              
                                                                                                                                                                           
                                                                                                                                                                           
 Non-GAAP Income               Three Months Ended                                                                                                                          
 Statement Items               January 3, 2009                                                                                                                             
                               GAAP                GAAP                       Stock                  Termination            Non-GAAP            Non-GAAP         
                               Measure             Percent of                 Compensation           Costs and              Measure             Percent of       
                                                   Revenue                    Expense                Impairments                                Revenue          
 Revenues                      $      99,348                                                                                                                    
                                                                                                                                                                 
 Operating expenses                   53,008             53.4   %          $        9,690        $        1,859        $      41,459      41.7    %       


 Silicon Laboratories Inc.                                                                                                
 
Condensed Consolidated Balance Sheets                                                                                   
 
(In thousands, except per share data)                                                                                   
 
(Unaudited)                                                                                                             
                                                                                                                      
                                                                      April 4,                 January 3,             
                                                                      2009                     2009                   
 Assets                                                                                                               
 Current assets:                                                                                                      
 Cash and cash equivalents                                            $     181,828          $     172,272        
 Short-term investments                                                     93,838                 101,267        
 Accounts receivable, net of allowance for doubtful accounts of             44,639                 36,144         
 $680 at April 4, 2009 and $1,011 at January 3, 2009                                                              
 Inventories                                                                23,525                 28,293         
 Deferred income taxes                                                      6,066                  6,439          
 Prepaid expenses and other current assets                                  21,102                 18,297         
 Total current assets                                                       370,998                362,712        
 Long-term investments                                                      50,799                 51,821         
 Property, equipment and software, net                                      29,065                 30,496         
 Goodwill                                                                   105,188                105,515        
 Other intangible assets, net                                               47,752                 49,728         
 Other assets, net                                                          18,975                 23,973         
 Total assets                                                         $     622,777          $     624,245        
                                                                                                                      
 Liabilities and Stockholders` Equity                                                                                 
 Current liabilities:                                                                                                 
 Accounts payable                                                     $     20,025           $     22,274         
 Accrued expenses                                                           25,558                 29,119         
 Deferred income on shipments to distributors                               21,154                 21,599         
 Income taxes                                                               78                     4              
 Total current liabilities                                                  66,815                 72,996         
 Long-term obligations and other liabilities                                49,068                 48,789         
 Total liabilities                                                          115,883                121,785        
 Commitments and contingencies                                                                                        
 Stockholders' equity:                                                                                                
 Preferred stock--$0.0001 par value; 10,000 shares authorized; no           --                     --             
 shares issued and outstanding                                                                                    
 Common stock--$0.0001 par value; 250,000 shares authorized;                4                      4              
 44,589 and 44,613 shares issued and outstanding at                                                               
 
April 4, 2009 and January 3, 2009, respectively                                                                 
 Additional paid-in capital                                                 79,461                 75,711         
 Retained earnings                                                          433,464                432,793        
 Accumulated other comprehensive loss                                       (6,035   )             (6,048   )     
 Total stockholders' equity                                                 506,894                502,460        
 Total liabilities and stockholders' equity                           $     622,777          $     624,245        


 Silicon Laboratories Inc.                                                                                                                
 
Condensed Consolidated Statements of Cash Flows                                                                                         
 
(In thousands)                                                                                                                          
 
(Unaudited)                                                                                                                             
                                                                                                                                        
                                                                                  Three Months Ended                                    
                                                                                  April 4,                    April 5,                
                                                                                  2009                        2008                    
 Operating Activities                                                                                                                 
 Net income                                                                       $     671                 $     10,814          
 Adjustments to reconcile net income to cash provided by operating activities:                                                        
 Depreciation and amortization of property, equipment and software                      2,953                     2,621           
 Loss (gain) on disposal of property, equipment and software                            8                         (15       )     
 Amortization of other intangible assets and other assets                               1,976                     1,032           
 Stock compensation expense                                                             10,149                    10,221          
 Income tax benefit (detriment) from employee stock-based awards                        (118     )                602             
 Excess income tax benefit from employee stock-based awards                             (50      )                (411      )     
 Deferred income taxes                                                                  3,589                     (262      )     
 Changes in operating assets and liabilities:                                                                                         
 Trading securities                                                                     2,600                     --              
 Accounts receivable                                                                    (8,168   )                4,856           
 Inventories                                                                            4,781                     1,666           
 Prepaid expenses and other assets                                                      2,237                     2,440           
 Accounts payable                                                                       (2,105   )                (4,435    )     
 Accrued expenses                                                                       (3,753   )                (4,989    )     
 Deferred income on shipments to distributors                                           (445     )                (842      )     
 Income taxes                                                                           (2,568   )                351             
 Net cash provided by operating activities                                              11,757                    23,649          
 Investing Activities                                                                                                                 
 Purchases of available-for-sale investments                                            (16,458  )                (79,237   )     
 Proceeds from sales and maturities of available-for-sale investments                   22,095                    248,818         
 Purchases of property, equipment and software                                          (1,531   )                (1,278    )     
 Proceeds from the sale of assets                                                       --                        14,265          
 Purchases of other assets                                                              (499     )                (183      )     
 Net cash provided by investing activities                                              3,607                     182,385         
 Financing Activities                                                                                                                 
 Proceeds from issuance of common stock                                                 661                       4,534           
 Excess income tax benefit from employee stock-based awards                             50                        411             
 Repurchases of common stock                                                            (5,023   )                (143,022  )     
 Repurchases of stock to satisfy employee tax withholding                               (1,496   )                (1,494    )     
 Net cash used in financing activities                                                  (5,808   )                (139,571  )     
                                                                                                                                      
 Increase in cash and cash equivalents                                                  9,556                     66,463          
 Cash and cash equivalents at beginning of period                                       172,272                   264,408         
 Cash and cash equivalents at end of period                                       $     181,828             $     330,871         


Silicon Laboratories Inc., Austin
Shannon Pleasant, 512-464-9254
shannon.pleasant@silabs.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.